Patents Represented by Attorney Michael A. Yamin

Find this attorney in the Justia Lawyer Directory

  • Hepatocyte growth factor pathway activators in fibrotic connective tissue diseases
    Patent number: 8193177
    Abstract: Methods are provided for treating fibrotic connective tissue diseases such as scleroderma and conditions such as surgically-induced adhesions using compounds that activate the signaling pathways of hepatocyte growth factor.
    Type: Grant
    Filed: November 13, 2008
    Date of Patent: June 5, 2012
    Assignee: Angion Biomedica Corp.
    Inventor: Latha Paka
  • Hepatocyte growth factor pathway activators in chronic obstructive pulmonary disease
    Patent number: 7879898
    Abstract: Methods are provided for treating chronic obstructive pulmonary diseases such as emphysema using compounds that activate the signaling pathways of hepatocyte growth factor.
    Type: Grant
    Filed: February 12, 2007
    Date of Patent: February 1, 2011
    Assignee: Angion Biomedica Corp.
    Inventor: Yanchun He
  • Sustained release delivery systems for solutes
    Patent number: 7090861
    Abstract: The present invention relates to devices that allow for linear, sustained-release of solutes with adjustable initial-release kinetics. In particular, the present invention relates to devices for delivering substances to the body of an animal. The present invention also relates to methods for delivering solutes in a constant, sustained-release fashion using the devices of the invention.
    Type: Grant
    Filed: March 19, 2003
    Date of Patent: August 15, 2006
    Assignee: Farrington Pharmaceuticals, LLC
    Inventors: Michael L. Brines, Anthony Cerami, Jean-Paul Wuerth